Zewen Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zewen Chen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Yifan Li
Guangdong Provincial Key Laboratory of South China Structural Heart Disease, 510080 Guangzhou, Guangdong, China
3 shared publicationsHailong Qiu
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080 Guangzhou, Guangdong, China
2 shared publicationsJimei Chen
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 510080 Guangzhou, Guangdong, China
2 shared publicationsShusheng Wen
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 510080 Guangzhou, Guangdong, China
2 shared publications- Shusheng Wen
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080 Guangzhou, Guangdong, China
2 shared publications Tianyu Chen
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080 Guangzhou, Guangdong, China
2 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (9)
Surgical Repair of an Isolated Giant Aortic Arch Aneurysm in an 11-Year-Old Girl: A Case Report
Background: Aortic arch aneurysms are exceedingly rare in children and are typically associated with connective tissue disorders, aortitis, infection, or trauma. Their management is challenging due to limited evidence guiding operative and perioperative strategies. This case describes the successful surgical repair of an isolated giant aortic arch and descending aorta aneurysm in a child, emphasizing key considerations for planning and execution. Case: An 11-year-old girl presented with a one-month history of exertional chest pain. Computed tomography (CT) revealed a 42 × 36 mm saccular aneurysm involving the distal aortic arch and proximal descending aorta, accompanied by an aberrant left subclavian artery (LSCA). Three-dimensional (3D) CT reconstruction and 3D-printed modeling facilitated operative planning. Through a left posterolateral thoracotomy and without cardiopulmonary bypass, the aneurysm was partially resected, preserving the recurrent laryngeal nerve, and the arch was reconstructed using a 14-mm Dacron graft. Cross-clamp time was 15 minutes. The patient recovered uneventfully and was discharged on postoperative day 3. Histopathology showed degeneration of the aortic wall without inflammation. Conclusions: This case highlights the importance of comprehensive preoperative imaging, individualized clamping strategy selection, and meticulous protection of adjacent structures in pediatric aortic arch aneurysm repair. These principles, consistent with approaches used for complex arch pathology, contribute to optimizing surgical safety and outcomes in this rare population.
- 8 September 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (9)
Open AccessSurgical Repair of an Isolated Giant Aortic Arch Aneurysm in an 11-Year-Old Girl: A Case Report
Background: Aortic arch aneurysms are exceedingly rare in children and are typically associated with connective tissue disorders, aortitis, infection, or trauma. Their management is challenging due to limited evidence guiding operative and perioperative strategies. This case describes the successful surgical repair of an isolated giant aortic arch and descending aorta aneurysm in a child, emphasizing key considerations for planning and execution. Case: An 11-year-old girl presented with a one-month history of exertional chest pain. Computed tomography (CT) revealed a 42 × 36 mm saccular aneurysm involving the distal aortic arch and proximal descending aorta, accompanied by an aberrant left subclavian artery (LSCA). Three-dimensional (3D) CT reconstruction and 3D-printed modeling facilitated operative planning. Through a left posterolateral thoracotomy and without cardiopulmonary bypass, the aneurysm was partially resected, preserving the recurrent laryngeal nerve, and the arch was reconstructed using a 14-mm Dacron graft. Cross-clamp time was 15 minutes. The patient recovered uneventfully and was discharged on postoperative day 3. Histopathology showed degeneration of the aortic wall without inflammation. Conclusions: This case highlights the importance of comprehensive preoperative imaging, individualized clamping strategy selection, and meticulous protection of adjacent structures in pediatric aortic arch aneurysm repair. These principles, consistent with approaches used for complex arch pathology, contribute to optimizing surgical safety and outcomes in this rare population.
- Open Access
- 20 August 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (8)
AAOCA and ALCAPA Are Distinct Congenital Coronary Anomalies With Different Pathophysiology and Management
- 20 August 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (8)
Open AccessAAOCA and ALCAPA Are Distinct Congenital Coronary Anomalies With Different Pathophysiology and Management
- Open Access
- 2 April 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (4)
DNA Methylation and Fetal Programming of Cardiovascular Disease: From Congenital Heart Diseases to Adult Cardiovascular Dysfunction
DNA methylation, the most extensively studied epigenetic mechanism, acts as a critical interface between maternal environmental influences and fetal cardiovascular development. During embryogenesis, tightly orchestrated methylation remodeling regulates the transcriptional networks required for cardiogenesis, including chamber septation, valve formation, and myocardial maturation. Disruption of these methylation patterns contributes to congenital heart disease (CHD), with distinct methylation signatures identified in tetralogy of Fallot, double-outlet right ventricle, bicuspid aortic valve, and coarctation of the aorta. Maternal exposures, including smoking, alcohol intake, folic acid status, hypertension, diabetes, and hyperlipidemia, modify fetal DNA methylation in placental, myocardial, and cord blood tissues. These alterations affect key developmental pathways, including Wnt, Notch, and mitogen-activated protein kinase signaling, as well as genes that regulate oxidative stress, thereby increasing the risk of structural defects and predisposing offspring to long-term cardiovascular vulnerability. Epigenetic reprogramming in adverse intrauterine environments has been linked to hypertension, pulmonary vascular disease, atherosclerosis, and ischemia-sensitive phenotypes in later life, supporting a continuum from fetal life to adult cardiovascular dysfunction. Unlike genetic mutations, DNA methylation is dynamic and reversible, highlighting the potential of this modification as a biomarker of early risk and a target for preventive strategies. Optimizing maternal health, ensuring appropriate folate intake, and reducing harmful exposures may help preserve normal methylation landscapes and improve offspring cardiovascular outcomes. Advances in high-resolution epigenomic profiling, including single-cell methylation technologies, now enable delineation of cell-specific trajectories that connect CHD with adult cardiovascular disease and may inform precision interventions aimed at modifying pathogenic epigenetic states. Thus, understanding the role of DNA methylation in fetal programming can clarify the developmental origins of CHD and adult cardiovascular disorders, and lay the foundation for cardiovascular prevention strategies that extend from preconception through the earliest stages of life.
- 2 April 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (4)
Open AccessDNA Methylation and Fetal Programming of Cardiovascular Disease: From Congenital Heart Diseases to Adult Cardiovascular Dysfunction
DNA methylation, the most extensively studied epigenetic mechanism, acts as a critical interface between maternal environmental influences and fetal cardiovascular development. During embryogenesis, tightly orchestrated methylation remodeling regulates the transcriptional networks required for cardiogenesis, including chamber septation, valve formation, and myocardial maturation. Disruption of these methylation patterns contributes to congenital heart disease (CHD), with distinct methylation signatures identified in tetralogy of Fallot, double-outlet right ventricle, bicuspid aortic valve, and coarctation of the aorta. Maternal exposures, including smoking, alcohol intake, folic acid status, hypertension, diabetes, and hyperlipidemia, modify fetal DNA methylation in placental, myocardial, and cord blood tissues. These alterations affect key developmental pathways, including Wnt, Notch, and mitogen-activated protein kinase signaling, as well as genes that regulate oxidative stress, thereby increasing the risk of structural defects and predisposing offspring to long-term cardiovascular vulnerability. Epigenetic reprogramming in adverse intrauterine environments has been linked to hypertension, pulmonary vascular disease, atherosclerosis, and ischemia-sensitive phenotypes in later life, supporting a continuum from fetal life to adult cardiovascular dysfunction. Unlike genetic mutations, DNA methylation is dynamic and reversible, highlighting the potential of this modification as a biomarker of early risk and a target for preventive strategies. Optimizing maternal health, ensuring appropriate folate intake, and reducing harmful exposures may help preserve normal methylation landscapes and improve offspring cardiovascular outcomes. Advances in high-resolution epigenomic profiling, including single-cell methylation technologies, now enable delineation of cell-specific trajectories that connect CHD with adult cardiovascular disease and may inform precision interventions aimed at modifying pathogenic epigenetic states. Thus, understanding the role of DNA methylation in fetal programming can clarify the developmental origins of CHD and adult cardiovascular disorders, and lay the foundation for cardiovascular prevention strategies that extend from preconception through the earliest stages of life.
- Open Access
- 16 January 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (1)
Repair of Partial and Transitional Atrioventricular Septal Defects: Mid-term Outcomes in a Single-center Cohort
Background: Surgical repair of partial and transitional atrioventricular septal defects (AVSDs) aims to achieve optimal outcomes with minimal need for reintervention. This study aimed to evaluate the mid-term outcomes of AVSD repair in both pediatric and adult populations. Methods: We retrospectively reviewed all patients who underwent surgical repair for partial or transitional AVSDs at our center between January 2019 and December 2022. Key outcomes, including mortality, reoperation, and atrioventricular valve (AVV) repair strategies, were assessed during follow-up. Results: A total of 136 patients were included (partial AVSD, n = 100; transitional AVSD, n = 36), with a median follow-up of 50.5 months. The median hospital stay was 14 days. No early or late deaths occurred. Reoperation was required in four patients (2.9%); all reoperations included left atrioventricular valve (LAVV) reoperation. However, reoperation rates did not differ significantly between AVSD subtypes (p = 1.000) or age groups (p = 0.177). The incidence of moderate or greater LAVV regurgitation showed no significant difference between patients with and without ring annuloplasty, either postoperatively or at the final follow-up (both p = 1.000). Conclusions: Surgical repair of partial and transitional AVSDs results in excellent mid-term survival and a low reoperation rate across both pediatric and adult patients. Continued refinement of AVV repair strategies remains essential to reduce the risk of LAVV reintervention and prevent left ventricular outflow tract obstruction. Long-term follow-up is warranted to improve the evaluation of the durability of techniques such as suture annuloplasty and ring annuloplasty.
- 16 January 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (1)
Open AccessRepair of Partial and Transitional Atrioventricular Septal Defects: Mid-term Outcomes in a Single-center Cohort
Background: Surgical repair of partial and transitional atrioventricular septal defects (AVSDs) aims to achieve optimal outcomes with minimal need for reintervention. This study aimed to evaluate the mid-term outcomes of AVSD repair in both pediatric and adult populations. Methods: We retrospectively reviewed all patients who underwent surgical repair for partial or transitional AVSDs at our center between January 2019 and December 2022. Key outcomes, including mortality, reoperation, and atrioventricular valve (AVV) repair strategies, were assessed during follow-up. Results: A total of 136 patients were included (partial AVSD, n = 100; transitional AVSD, n = 36), with a median follow-up of 50.5 months. The median hospital stay was 14 days. No early or late deaths occurred. Reoperation was required in four patients (2.9%); all reoperations included left atrioventricular valve (LAVV) reoperation. However, reoperation rates did not differ significantly between AVSD subtypes (p = 1.000) or age groups (p = 0.177). The incidence of moderate or greater LAVV regurgitation showed no significant difference between patients with and without ring annuloplasty, either postoperatively or at the final follow-up (both p = 1.000). Conclusions: Surgical repair of partial and transitional AVSDs results in excellent mid-term survival and a low reoperation rate across both pediatric and adult patients. Continued refinement of AVV repair strategies remains essential to reduce the risk of LAVV reintervention and prevent left ventricular outflow tract obstruction. Long-term follow-up is warranted to improve the evaluation of the durability of techniques such as suture annuloplasty and ring annuloplasty.
- Open Access
- 6 January 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (1) , 1-17
LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells
Long non-coding RNA (lncRNA) DANCR has been reported to participate in key processes such as stem cell differentiation and tumorigenesis. In a high throughput screening for lncRNAs involved in Doxorubicin-induced apoptosis, we found DANCR was suppressed by Doxorubicin and it acted as an important repressor of apoptosis in colorectal cancer. Further studies demonstrated that DANCR promoted the oncogenic lncRNA MALAT1 expression via enhancing the RNA stability of MALAT1 to suppress apoptosis. MALAT1 could efficiently mediate the suppressive function of DANCR on apoptosis. Mechanistic studies found the RNA-binding protein QK served as an interacting partner of both DANCR and MALAT1, and the protein level of QK was subjected to the regulation by DANCR. Furthermore, QK was able to modulate the RNA stability of MALAT1, and the interaction between QK and MALAT1 was controlled by DANCR. In addition, QK could mediate the function of DANCR in regulating the expression of MALAT1 and suppressing apoptosis. These results revealed DANCR played a critical role in Doxorubicin-induced apoptosis in colorectal cancer cells, which was achieved by the interaction between DANCR and QK to enhance the expression of MALAT1.
- 6 January 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (1) , 1-17
Open AccessLncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells
Long non-coding RNA (lncRNA) DANCR has been reported to participate in key processes such as stem cell differentiation and tumorigenesis. In a high throughput screening for lncRNAs involved in Doxorubicin-induced apoptosis, we found DANCR was suppressed by Doxorubicin and it acted as an important repressor of apoptosis in colorectal cancer. Further studies demonstrated that DANCR promoted the oncogenic lncRNA MALAT1 expression via enhancing the RNA stability of MALAT1 to suppress apoptosis. MALAT1 could efficiently mediate the suppressive function of DANCR on apoptosis. Mechanistic studies found the RNA-binding protein QK served as an interacting partner of both DANCR and MALAT1, and the protein level of QK was subjected to the regulation by DANCR. Furthermore, QK was able to modulate the RNA stability of MALAT1, and the interaction between QK and MALAT1 was controlled by DANCR. In addition, QK could mediate the function of DANCR in regulating the expression of MALAT1 and suppressing apoptosis. These results revealed DANCR played a critical role in Doxorubicin-induced apoptosis in colorectal cancer cells, which was achieved by the interaction between DANCR and QK to enhance the expression of MALAT1.